VigorPeak safety: the questions to ask before a capsule.

FDA context matters

In the United States, FDA does not approve dietary supplements for safety and effectiveness before they are marketed. Manufacturers and distributors are responsible for complying with the law, and FDA has post-market oversight. Therefore, phrases such as “made in an FDA-registered facility” should never be read as FDA approval of the product.

Talk with a healthcare professional first if...

• You take prescription medication or multiple supplements.
• You have cardiovascular disease, blood-pressure problems, liver or kidney disease, or a hormone-sensitive condition.
• You are being evaluated for prostate symptoms, low testosterone, infertility or erectile dysfunction.
• You have persistent fatigue, depression, sleep problems or unexplained changes in sexual function.
• You have had a prior adverse reaction to botanical supplements.

Ingredient-specific caution is more useful than “natural = safe”

Saw palmetto is generally well tolerated in research, according to NCCIH, but it can cause digestive symptoms, dizziness or headache. Boron has an adult tolerable upper intake level of 20 mg/day according to NIH ODS; VigorPeak's label wording is 20 mg of a 5% boron amino acid chelate ingredient, which should not be casually read as 20 mg elemental boron.

Red flags a supplement page should not diagnose

Chest pain, severe shortness of breath, fainting, neurologic symptoms, a painful or prolonged erection, or any acute severe reaction requires urgent medical care. Sudden or persistent sexual-function changes can also be an early sign of broader health issues and deserve clinical discussion.

See our source notes for FDA, NIH and NCCIH references.